Assessment of the potential value of combining western medicine therapies with traditional chinese medicine in the treatment of COVID-19: Mechanistic perspectives

被引:0
作者
Zeng, Zirui [1 ,2 ]
机构
[1] South China Normal Univ, Int Dept, Affiliated High Sch, Guangzhou, Guangdong, Peoples R China
[2] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA
关键词
SARS-CoV-2; COVID-19; traditional Chinese medicine; therapies; ACUTE RESPIRATORY SYNDROME; JINHUA QINGGAN GRANULES; SARS CORONAVIRUS; NETWORK PHARMACOLOGY; EMODIN; PNEUMONIA; LICORICE; RECEPTOR; PROTEIN; ACE2;
D O I
10.3233/THC-236015
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: The pandemic caused by the novel coronavirus disease (COVID-19) since early 2020 is one of the most significant global health issues in history. Although there is currently no specific treatment for COVID-19, researchers have provided a whole array of potential treatments, both from the Western medicine approach, which is molecular target and pathogenesis based, and from the traditional Chinese medicine (TCM) approach, which is based on the exposure to toxins/pathogens and the balance of the body to combat them for recovery. OBJECTIVE: The aim of this research is to find combinations of Western medicine and TCM that may offer better therapeutic efficacy synergystically with a better adverse events profile. The findings of the research may provide a new insight in the development of the treatment of COVID-19. METHODS: From the Western medicine perspective, drugs target the mechanisms of viral infection, including the stages of viral entry (Arbidol, Camostat Mesylate, Convalescent Plasma therapy) and viral replication (Lopinavir/Ritonavir, Redemsivir, Ribavirin). Additional therapies target host defenses, preventing cytokine storms (Tocilizumab) and stimulating the immune system (Interferons). On the other hand, TCM also proposed a number of treatment methods for COVID-19 with new scientific approaches identifying their antiviral and immunomodulatory activities. The novel combination of Western medicine and TCM can be proposed by analyzing their respective molecular targets. RESULTS: Although TCM is not generally accepted in the Western community because of the general lack of knowledge on their detailed mechanisms, studies and clinical trials suggest that TCM could be beneficial in combating COVID-19. CONCLUSION: Based on the principle of combining TCM and Western medicine, two combinations are tested effective in clinical trials, and three possible combinations that might be effective are proposed in the paper.
引用
收藏
页码:S169 / S184
页数:16
相关论文
共 83 条
[1]   Arbidol as a broad-spectrum antiviral: An update [J].
Blaising, Julie ;
Polyak, Stephen J. ;
Pecheur, Eve-Isabelle .
ANTIVIRAL RESEARCH, 2014, 107 :84-94
[2]  
Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]
[3]  
Cao C., 2019, J TRANSL SCI, V6, P1
[4]   Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence [J].
Cao, Yu-chen ;
Deng, Qi-xin ;
Dai, Shi-xue .
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 35
[5]   Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica [J].
Chan, Kelvin ;
Shaw, Debbie ;
Simmonds, Monique S. J. ;
Leon, Christine J. ;
Xu, Qihe ;
Lu, Aiping ;
Sutherland, Ian ;
Ignatova, Svetlana ;
Zhu, You-Ping ;
Verpoorte, Rob ;
Williamson, Elizabeth M. ;
Duez, Pierre .
JOURNAL OF ETHNOPHARMACOLOGY, 2012, 140 (03) :469-475
[6]  
Chandwani Ashish, 2008, Ther Clin Risk Manag, V4, P1023
[7]  
Chen S, 2011, CHIN COMMUN DOCTORS, V13
[8]  
Chen Y, 2020, PSYCHOL, V15, P190
[9]   Advances in the possible treatment of COVID-19: A review [J].
Chibber, Pankaj ;
Haq, Syed Assim ;
Ahmed, Irfan ;
Andrabi, Nusrit Iqbal ;
Singh, Gurdarshan .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 883
[10]   Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [J].
Choudhry, Namrta ;
Zhao, Xin ;
Xu, Dan ;
Zanin, Mark ;
Chen, Weisan ;
Yang, Zifeng ;
Chen, Jianxin .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (22) :13205-13227